
### [NCIT:C7635](http://purl.obolibrary.org/obo/NCIT_C7635)
**Label:** Well Differentiated Papillary Mesothelioma

**Subclasses:** [NCIT:C45661](http://purl.obolibrary.org/obo/NCIT_C45661) (Peritoneal Well Differentiated Papillary Mesothelioma), [NCIT:C45660](http://purl.obolibrary.org/obo/NCIT_C45660) (Pleural Well Differentiated Papillary Mesothelioma), 

**Class expressions from DL-Learner:**

- [NCIT:C36133](http://purl.obolibrary.org/obo/NCIT_C36133) (Well Differentiated Lesion) 54.17%
- [NCIT:C41039](http://purl.obolibrary.org/obo/NCIT_C41039) (Localized Lesion) and (not ([NCIT:C39688](http://purl.obolibrary.org/obo/NCIT_C39688) (Localized Skin Lesion))) 54.17%
- Thing 52.77%
- [NCIT:C41039](http://purl.obolibrary.org/obo/NCIT_C41039) (Localized Lesion) 39.52%
- [NCIT:C41039](http://purl.obolibrary.org/obo/NCIT_C41039) (Localized Lesion) and (not ([NCIT:C40147](http://purl.obolibrary.org/obo/NCIT_C40147) (Grade 2 Endometrial Endometrioid Adenocarcinoma))) 39.52%
- [NCIT:C41039](http://purl.obolibrary.org/obo/NCIT_C41039) (Localized Lesion) and (not ([NCIT:C40146](http://purl.obolibrary.org/obo/NCIT_C40146) (Grade 1 Endometrial Endometrioid Adenocarcinoma))) 39.52%
- [NCIT:C41039](http://purl.obolibrary.org/obo/NCIT_C41039) (Localized Lesion) and (not ([NCIT:C40142](http://purl.obolibrary.org/obo/NCIT_C40142) (Uterine Ligament Papillary Cystadenoma Associated with von Hippel-Lindau Disease))) 39.52%
- [NCIT:C41039](http://purl.obolibrary.org/obo/NCIT_C41039) (Localized Lesion) and (not ([NCIT:C40141](http://purl.obolibrary.org/obo/NCIT_C40141) (Wolffian Adnexal Tumor))) 39.52%
- [NCIT:C41039](http://purl.obolibrary.org/obo/NCIT_C41039) (Localized Lesion) and (not ([NCIT:C40139](http://purl.obolibrary.org/obo/NCIT_C40139) (Uterine Ligament Clear Cell Adenocarcinoma))) 39.52%
- [NCIT:C41039](http://purl.obolibrary.org/obo/NCIT_C41039) (Localized Lesion) and (not ([NCIT:C40138](http://purl.obolibrary.org/obo/NCIT_C40138) (Uterine Ligament Endometrioid Adenocarcinoma))) 39.52%
- [NCIT:C41039](http://purl.obolibrary.org/obo/NCIT_C41039) (Localized Lesion) and (not ([NCIT:C40137](http://purl.obolibrary.org/obo/NCIT_C40137) (Uterine Ligament Mucinous Adenocarcinoma))) 39.52%
- [NCIT:C41039](http://purl.obolibrary.org/obo/NCIT_C41039) (Localized Lesion) and (not ([NCIT:C40129](http://purl.obolibrary.org/obo/NCIT_C40129) (Fallopian Tube Adenomatoid Tumor))) 39.52%
- [NCIT:C41039](http://purl.obolibrary.org/obo/NCIT_C41039) (Localized Lesion) and (not ([NCIT:C40128](http://purl.obolibrary.org/obo/NCIT_C40128) (Fallopian Tube Leiomyosarcoma))) 39.52%
- [NCIT:C41039](http://purl.obolibrary.org/obo/NCIT_C41039) (Localized Lesion) and (not ([NCIT:C40127](http://purl.obolibrary.org/obo/NCIT_C40127) (Fallopian Tube Leiomyoma))) 39.52%
- [NCIT:C41039](http://purl.obolibrary.org/obo/NCIT_C41039) (Localized Lesion) and (not ([NCIT:C40125](http://purl.obolibrary.org/obo/NCIT_C40125) (Fallopian Tube Adenosarcoma))) 39.52%


